PERSPECTA

News from every angle

← Back to headlines

Novo Nordisk Partners with Vivtex for Oral Drug-Delivery Technologies

Novo Nordisk's stock dipped after the company announced a $2.1 billion partnership with Vivtex to develop oral drug-delivery technologies.

25 Feb, 23:12 — 25 Feb, 23:12
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual41d ago

Stock Market Today, Feb. 25: Novo Nordisk Dips After Announcing $2.1 Billion Partnership With Vivtex for Oral Drug-Delivery Technologies

Read full article →

Related Stories

Philippine Justice Questions Identity of 'SBR' in Flood Control Project

just now

Philippine Government Addresses Supply Chain Concerns

just now

Brian Poe calls for ‘people’s hearing’ on oil crisis, energy reforms

just now

Manila Water Prepares for Summer Heat and High Demand

just now